VAERS Explorer
Back to explore

Report #2893203

Received Apr 19, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
Recovered
Recovered
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNK

Symptoms (2)

FearSeizure

Symptom narrative

I took the first shot, 12 hours later I went into bad convulsions; This serious case was reported by a consumer via interactive digital media and described the occurrence of convulsion in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 12 hrs after receiving Shingles vaccine, the patient experienced convulsion (Verbatim: I took the first shot, 12 hours later I went into bad convulsions) (serious criteria GSK medically significant). The outcome of the convulsion was resolved (duration 5 hrs). It was unknown if the reporter considered the convulsion to be related to Shingles vaccine. The company considered the convulsion to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 04-APR-2026 This case was reported by a patient via interactive digital media. The patient stated that the convulsions lasted about 5 hours and it was horrible. Now the patient was told he/she needed a second shot in a month or two and patient was really afraid to take it The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Seizure (not meeting BC Criteria), 12 hours after receiving 1st dose of Shingles vaccine in a patient. Case lacks further information on clinical details, medical history, concurrent conditions and concomitant medication. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received